Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Finished Goods (2022 - 2025)

TELA Bio has reported Finished Goods over the past 4 years, most recently at $10.9 million for Q4 2025.

  • For Q4 2025, Finished Goods fell 13.82% year-over-year to $10.9 million; the TTM value through Dec 2025 reached $10.9 million, down 13.82%, while the annual FY2025 figure was $10.9 million, 13.82% down from the prior year.
  • Finished Goods for Q4 2025 was $10.9 million at TELA Bio, down from $12.6 million in the prior quarter.
  • Over five years, Finished Goods peaked at $13.1 million in Q4 2023 and troughed at $10.9 million in Q4 2025.
  • A 4-year average of $12.1 million and a median of $12.2 million in 2022 define the central range for Finished Goods.
  • Biggest five-year swings in Finished Goods: rose 11.11% in 2023 and later decreased 13.82% in 2025.
  • Year by year, Finished Goods stood at $11.8 million in 2022, then increased by 11.11% to $13.1 million in 2023, then fell by 3.49% to $12.6 million in 2024, then dropped by 13.82% to $10.9 million in 2025.
  • Business Quant data shows Finished Goods for TELA at $10.9 million in Q4 2025, $12.6 million in Q4 2024, and $13.1 million in Q4 2023.